{
  "chunk_id": "BỆNH PELLAGRA_13",
  "disease": "BỆNH PELLAGRA",
  "section": "OVERVIEW",
  "file_name": "PELLAGRA.txt",
  "content": "68. Janet M. Torpy, Alison E. Burke, MA, Richard M. Glass (2008). \"JAMA patient page: Neurofibromatosis\". JAMA: the Journal of the American Medical Association 300(3):352–352.\n69. Jean- Claude Roujeau (2013). Drug reaction with eosinophilia and systemic symptoms, Uptodate.\n70. Jean R. Laurence Valeyrie A. (2008). Drug reactions. Dermatology 2nd Edition.\n71. Jeong SY, Shin JB, Yeo UC, Kim WS, Kim IH (2010). Low-Fluence Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser for Melasma with Pre- or Post-Treatment Triple Combination Cream. Dermatol Surg.\n72. John Hunter, John Savin and Mark Dahl (2008). Clinical Dermatology. Blackwell.\n73. Joseph F. Fowler, Alexander Fisher (2007). Fisher’s contact dermatitis. 6th edn, Pmph, American.\n74. Joseph L.J., Christie L.C., Omar P.S. (2008). Der\n75. Kai M, Nguyen Phuc NH, et al. (2011). Analysis of Drug-Resistant Strains of Mycobacterium leprae in an Endemic Area of Vietnam. Clin Infect Dis. 52(5).pp.127-132.\n76. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK (2008). Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 122(3).pp.569-573.\n77. Karp G, Schlaeffer F, Jotkowitz A, Riesenberg K (2009). Syphilis and HIV co-infection. Eur J Intern Med. 20(1).pp.9-13.\n78. Keller JJ, Lin HC (2012). The Effects of Chronic Periodontitis and Its Treatment on the Subsequent Risk of Psoriasis. Br J Dermatol.\n79. Kent ME, Romanelli F (Feb 2008). Reexamining syphilis: an update on epidemiology, clinical manifestations, and management. Ann Pharmacother. 42(2).pp.226-236.\n80. King K. Holmes, P. Frederick Sparling et al (2012). Sexually Transmitted Diseases/ McGraw-Hill Medical. Fourth Edition. p. 627-645.\n81. Kirtschig G, Khumalo NP (2004). Management of bullous pemphigoid: recommendations for immunomodulatory treatments. Am J Clin Dermatol. 5(5).pp.319-326."
}